Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Larixyl acetate | 4608-49-5 | 99.5% | 348.52 g/mol | C22H36O3 | 10 MG
SDP

Catalog No. 5000248170
Encompass_Preferred

Larixyl acetate is a diterpenoid research compound that acts as a potent, selective TRPC6 inhibitor with additional activity against TRPC3. It has reported protective effects in models of human papillomavirus impact and traumatic brain injury-induced endothelial dysfunction, and is supplied as a high-purity analytical standard for laboratory research.

  • Potent TRPC6 inhibitor (IC50: 0.58 μM).
  • Also inhibits TRPC3 (IC50: 6.83 μM).
  • High purity, approximately 99.5%.
  • Molecular weight 348.52 g/mol; formula C22H36O3.
  • Stable as a powder at -20°C for up to 3 years.
  • Provided as a 10 mg research-grade sample for analytical use.

Catalog No. 50-002-48170 Supplier Medchemexpress LLC Supplier No. HY10179510MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

Larixyl acetate is a diterpenoid research compound that acts as a potent, selective TRPC6 inhibitor with additional activity against TRPC3. It has reported protective effects in models of human papillomavirus impact and traumatic brain injury-induced endothelial dysfunction, and is supplied as a high-purity analytical standard for laboratory research.

  • Potent TRPC6 inhibitor (IC50: 0.58 μM).
  • Also inhibits TRPC3 (IC50: 6.83 μM).
  • High purity, approximately 99.5%.
  • Molecular weight 348.52 g/mol; formula C22H36O3.
  • Stable as a powder at -20°C for up to 3 years.
  • Provided as a 10 mg research-grade sample for analytical use.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.